Carl Icahn, the billionaire investor who Republican presidential candidate Donald Trump wants to name Secretary of the Treasury, is urging Congress to change the tax code so that companies don't have an incentive to move outside the U.S.
His latest warning followed confirmed merger talks between Pfizer Inc., the largest U.S. drugmaker, and Ireland-based Allergan Plc. The companies have a combined market value of about $320 billion, which would be a record-breaking deal for the pharmaceutical industry. Read more
Comments
Post a Comment